216 related articles for article (PubMed ID: 18264942)
1. Omega-3 polyunsaturated fatty acids and proxies of cardiovascular disease in hemodialysis: a prospective cohort study.
Vernaglione L; Cristofano C; Chimienti S
J Nephrol; 2008; 21(1):99-105. PubMed ID: 18264942
[TBL] [Abstract][Full Text] [Related]
2. Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study.
Szklarek-Kubicka M; Fijałkowska-Morawska J; Zaremba-Drobnik D; Uciński A; Czekalski S; Nowicki M
J Ren Nutr; 2009 Nov; 19(6):487-93. PubMed ID: 19616450
[TBL] [Abstract][Full Text] [Related]
3. Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients.
Ewers B; Riserus U; Marckmann P
J Ren Nutr; 2009 Sep; 19(5):401-11. PubMed ID: 19541503
[TBL] [Abstract][Full Text] [Related]
4. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
Madsen T; Schmidt EB; Christensen JH
J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424
[TBL] [Abstract][Full Text] [Related]
5. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[TBL] [Abstract][Full Text] [Related]
6. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients.
Bowden RG; Jitomir J; Wilson RL; Gentile M
J Ren Nutr; 2009 Jul; 19(4):259-66. PubMed ID: 19539180
[TBL] [Abstract][Full Text] [Related]
7. Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study.
Cicero AF; Derosa G; Di Gregori V; Bove M; Gaddi AV; Borghi C
Clin Exp Hypertens; 2010 Jan; 32(2):137-44. PubMed ID: 20374188
[TBL] [Abstract][Full Text] [Related]
8. Dietary supplementation with flaxseed oil lowers blood pressure in dyslipidaemic patients.
Paschos GK; Magkos F; Panagiotakos DB; Votteas V; Zampelas A
Eur J Clin Nutr; 2007 Oct; 61(10):1201-6. PubMed ID: 17268413
[TBL] [Abstract][Full Text] [Related]
9. Supplementation with n-3 and n-6 polyunsaturated fatty acids: effects on lipoxygenase activity and clinical symptoms of pruritus in hemodialysis patients.
Begum R; Belury MA; Burgess JR; Peck LW
J Ren Nutr; 2004 Oct; 14(4):233-41. PubMed ID: 15483784
[TBL] [Abstract][Full Text] [Related]
10. The effect of low dose omega-3 on plasma lipids in hemodialysis patients.
Taziki O; Lessan-Pezeshki M; Akha O; Vasheghani F
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):571-6. PubMed ID: 17951945
[TBL] [Abstract][Full Text] [Related]
11. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.
Burns T; Maciejewski SR; Hamilton WR; Zheng M; Mooss AN; Hilleman DE
Pharmacotherapy; 2007 May; 27(5):633-8. PubMed ID: 17461697
[TBL] [Abstract][Full Text] [Related]
12. Effect of a sardine supplement on C-reactive protein in patients receiving hemodialysis.
Moreira AC; Gaspar A; Serra MA; Simões J; Lopes da Cruz J; Amaral TF
J Ren Nutr; 2007 May; 17(3):205-13. PubMed ID: 17462553
[TBL] [Abstract][Full Text] [Related]
13. Long-term oral sodium bicarbonate supplementation does not improve serum albumin levels in hemodialysis patients.
Bossola M; Giungi S; Tazza L; Luciani G
Nephron Clin Pract; 2007; 106(1):c51-6. PubMed ID: 17409769
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 polyunsaturated fatty acid supplements and ambulatory blood pressure monitoring parameters in patients with mild essential hypertension.
Russo C; Olivieri O; Girelli D; Azzini M; Stanzial AM; Guarini P; Friso S; De Franceschi L; Corrocher R
J Hypertens; 1995 Dec; 13(12 Pt 2):1823-6. PubMed ID: 8903660
[TBL] [Abstract][Full Text] [Related]
15. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.
Rasic-Milutinovic Z; Perunicic G; Pljesa S; Gluvic Z; Sobajic S; Djuric I; Ristic D
Ren Fail; 2007; 29(3):321-9. PubMed ID: 17497447
[TBL] [Abstract][Full Text] [Related]
16. Evolution of lipid profile, liver function, and pattern of plasma fatty acids according to the type of lipid emulsion administered in parenteral nutrition in the early postoperative period after digestive surgery.
Puiggròs C; Sánchez J; Chacón P; Sabín P; Roselló J; Bou R; Planas M
JPEN J Parenter Enteral Nutr; 2009; 33(5):501-12. PubMed ID: 19420283
[TBL] [Abstract][Full Text] [Related]
17. The effect of n-3 fatty acids on heart rate variability in patients treated with chronic hemodialysis.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
J Ren Nutr; 2007 Jul; 17(4):243-9. PubMed ID: 17586422
[TBL] [Abstract][Full Text] [Related]
18. Impact of foods enriched with n-3 long-chain polyunsaturated fatty acids on erythrocyte n-3 levels and cardiovascular risk factors.
Murphy KJ; Meyer BJ; Mori TA; Burke V; Mansour J; Patch CS; Tapsell LC; Noakes M; Clifton PA; Barden A; Puddey IB; Beilin LJ; Howe PR
Br J Nutr; 2007 Apr; 97(4):749-57. PubMed ID: 17349088
[TBL] [Abstract][Full Text] [Related]
19. [Effect of n-3 polyunsaturated fatty acids on plasma lipid, LDL lipoperoxidation, homocysteine and inflammation indicators in diabetic dyslipidemia treated with statin + fibrate combination].
Zeman M; Zák A; Vecka M; Tvrzická E; Písaríková A; Stanková B
Cas Lek Cesk; 2005; 144(11):737-41. PubMed ID: 16335699
[TBL] [Abstract][Full Text] [Related]
20. Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function.
Schiano V; Laurenzano E; Brevetti G; De Maio JI; Lanero S; Scopacasa F; Chiariello M
Clin Nutr; 2008 Apr; 27(2):241-7. PubMed ID: 18237823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
